Long term follow up of von Willebrand factor and plasminogen activator inhibitor-1 in patients with polymyalgia rheumatica
Open Access
- 1 November 1997
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 56 (11) , 698-699
- https://doi.org/10.1136/ard.56.11.698
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.Annals of the Rheumatic Diseases, 1993
- Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumaticaClinical Rheumatology, 1992
- von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis.Annals of the Rheumatic Diseases, 1991
- Biochemical and biological aspects of the plasminogen activation systemClinical Biochemistry, 1990
- Increased von willebrand factor antigen in the plasma of patients with vasculitisArthritis & Rheumatism, 1984
- Elevation of von willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritisArthritis & Rheumatism, 1984
- An evaluation of criteria for polymyalgia rheumatica.Annals of the Rheumatic Diseases, 1979
- Increased von Willebrand factor in diabetes mellitusMetabolism, 1979
- Synthesis of von Willebrand Factor by Cultured Human Endothelial CellsProceedings of the National Academy of Sciences, 1974
- ARTHRITIS IN "POLYMYALGIA RHEUMATICA"The Lancet, 1964